DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 23, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024. DexCom describes itself as an "international company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management." A class action has already been filed. If you wish to serve as lead plaintiff, you must move ...